Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-label, Multicenter, Follow-up Phase III Study to Investigate the Safety of the Third Vaccination of FSME-IMMUN NEW in Volunteers Aged 16 to 66 Years

NCT00161876 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00161876
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00161876 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-label, Multicenter, Follow-up Phase III Study to Investigate the Safety of the Third Vaccination of FSME-IMMUN NEW in Volunteers Aged 16 to 66 Years
Lead sponsor
Pfizer
Phase
Phase 3
Overall status
Completed
Start date
May 31, 2002
Completion date
August 31, 2002
Enrollment
3,973
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

encephalitis, tick-borne